Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 171 entries
Sorted by: Best Match Show Resources per page
[Assessment of the Therapeutic Efficacy and Safety of the Original Bisoprolol and its Generic Biprol in Patients With Stable Angina].

Kardiologiia

Karlova NA, Zolozova EA, Pshenitsin AI, Chigineva VV, Karlov AA, Sayutina EV, Solomasova LV, Mazur NA.
PMID: 28294822
Kardiologiia. 2015 Jan;55(1):23-28.

No abstract available.

Cite
Karlova NA, Zolozova EA, Pshenitsin AI, et al. [Assessment of the Therapeutic Efficacy and Safety of the Original Bisoprolol and its Generic Biprol in Patients With Stable Angina]. Kardiologiia. 2015;55(1):23-28
Karlova, N. A., Zolozova, E. A., Pshenitsin, A. I., Chigineva, V. V., Karlov, A. A., Sayutina, E. V., Solomasova, L. V., & Mazur, N. A. (2015). [Assessment of the Therapeutic Efficacy and Safety of the Original Bisoprolol and its Generic Biprol in Patients With Stable Angina]. Kardiologiia, 55(1), 23-28.
Karlova, N A, et al. "[Assessment of the Therapeutic Efficacy and Safety of the Original Bisoprolol and its Generic Biprol in Patients With Stable Angina]." Kardiologiia vol. 55,1 (2015): 23-28.
Karlova NA, Zolozova EA, Pshenitsin AI, Chigineva VV, Karlov AA, Sayutina EV, Solomasova LV, Mazur NA. [Assessment of the Therapeutic Efficacy and Safety of the Original Bisoprolol and its Generic Biprol in Patients With Stable Angina]. Kardiologiia. 2015 Jan;55(1):23-28. Russian. PMID: 28294822.
Copy Download .nbib Format: NLM
Recurrent syncope in two patients with a sigmoid-shaped interventricular septum and no left ventricular hypertrophy.

Journal of arrhythmia

Yamaguchi Y, Mizumaki K, Iwamoto J, Nishida K, Sakamoto T, Nakatani Y, Kataoka N, Inoue H.
PMID: 26702321
J Arrhythm. 2015 Dec;31(6):391-4. doi: 10.1016/j.joa.2015.04.006. Epub 2015 May 28.

Sigmoid-shaped interventricular septum (SIS) is not uncommon in elderly patients and is considered a normal part of the aging process. However, several patients have been reported to have clinical symptoms due to the narrowing of the left ventricular outflow...

Cite
Yamaguchi Y, Mizumaki K, Iwamoto J, et al. Recurrent syncope in two patients with a sigmoid-shaped interventricular septum and no left ventricular hypertrophy. J Arrhythm. 2015;31(6):391-4doi: 10.1016/j.joa.2015.04.006.
Yamaguchi, Y., Mizumaki, K., Iwamoto, J., Nishida, K., Sakamoto, T., Nakatani, Y., Kataoka, N., & Inoue, H. (2015). Recurrent syncope in two patients with a sigmoid-shaped interventricular septum and no left ventricular hypertrophy. Journal of arrhythmia, 31(6), 391-4. https://doi.org/10.1016/j.joa.2015.04.006
Yamaguchi, Yoshiaki, et al. "Recurrent syncope in two patients with a sigmoid-shaped interventricular septum and no left ventricular hypertrophy." Journal of arrhythmia vol. 31,6 (2015): 391-4. doi: https://doi.org/10.1016/j.joa.2015.04.006
Yamaguchi Y, Mizumaki K, Iwamoto J, Nishida K, Sakamoto T, Nakatani Y, Kataoka N, Inoue H. Recurrent syncope in two patients with a sigmoid-shaped interventricular septum and no left ventricular hypertrophy. J Arrhythm. 2015 Dec;31(6):391-4. doi: 10.1016/j.joa.2015.04.006. Epub 2015 May 28. PMID: 26702321; PMCID: PMC4672037.
Copy Download .nbib Format: NLM
Beta-Blockers and Oxidative Stress in Patients with Heart Failure.

Pharmaceuticals (Basel, Switzerland)

Nakamura K, Murakami M, Miura D, Yunoki K, Enko K, Tanaka M, Saito Y, Nishii N, Miyoshi T, Yoshida M, Oe H, Toh N, Nagase S, Kohno K, Morita H, Matsubara H, Kusano KF, Ohe T, Ito H.
PMID: 26791643
Pharmaceuticals (Basel). 2011 Aug 05;4(8):1088-100. doi: 10.3390/ph4081088.

Oxidative stress has been implicated in the pathogenesis of heart failure. Reactive oxygen species (ROS) are produced in the failing myocardium, and ROS cause hypertrophy, apoptosis/cell death and intracellular Ca(2+) overload in cardiac myocytes. ROS also cause damage to...

Cite
Nakamura K, Murakami M, Miura D, et al. Beta-Blockers and Oxidative Stress in Patients with Heart Failure. Pharmaceuticals (Basel). 2011;4(8):1088-100doi: 10.3390/ph4081088.
Nakamura, K., Murakami, M., Miura, D., Yunoki, K., Enko, K., Tanaka, M., Saito, Y., Nishii, N., Miyoshi, T., Yoshida, M., Oe, H., Toh, N., Nagase, S., Kohno, K., Morita, H., Matsubara, H., Kusano, K. F., Ohe, T., & Ito, H. (2011). Beta-Blockers and Oxidative Stress in Patients with Heart Failure. Pharmaceuticals (Basel, Switzerland), 4(8), 1088-100. https://doi.org/10.3390/ph4081088
Nakamura, Kazufumi, et al. "Beta-Blockers and Oxidative Stress in Patients with Heart Failure." Pharmaceuticals (Basel, Switzerland) vol. 4,8 (2011): 1088-100. doi: https://doi.org/10.3390/ph4081088
Nakamura K, Murakami M, Miura D, Yunoki K, Enko K, Tanaka M, Saito Y, Nishii N, Miyoshi T, Yoshida M, Oe H, Toh N, Nagase S, Kohno K, Morita H, Matsubara H, Kusano KF, Ohe T, Ito H. Beta-Blockers and Oxidative Stress in Patients with Heart Failure. Pharmaceuticals (Basel). 2011 Aug 05;4(8):1088-100. doi: 10.3390/ph4081088. PMID: 26791643; PMCID: PMC4058661.
Copy Download .nbib Format: NLM
Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results.

Therapeutics and clinical risk management

Metra M, Nodari S, Bordonali T, Milani P, Lombardi C, Bugatti S, Fontanella B, Verzura G, Danesi R, Dei Cas L.
PMID: 18472978
Ther Clin Risk Manag. 2007 Aug;3(4):569-78.

Clinical trials have consistently shown the benefits of beta-blocker treatment in patients with chronic heart failure (HF). As a result, bisoprolol, carvedilol, and metoprolol succinate are now indicated for the treatment of all patients with chronic HF who do...

Cite
Metra M, Nodari S, Bordonali T, et al. Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results. Ther Clin Risk Manag. 2007;3(4):569-78
Metra, M., Nodari, S., Bordonali, T., Milani, P., Lombardi, C., Bugatti, S., Fontanella, B., Verzura, G., Danesi, R., & Dei Cas, L. (2007). Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results. Therapeutics and clinical risk management, 3(4), 569-78.
Metra, Marco, et al. "Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results." Therapeutics and clinical risk management vol. 3,4 (2007): 569-78.
Metra M, Nodari S, Bordonali T, Milani P, Lombardi C, Bugatti S, Fontanella B, Verzura G, Danesi R, Dei Cas L. Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results. Ther Clin Risk Manag. 2007 Aug;3(4):569-78. PMID: 18472978; PMCID: PMC2374926.
Copy Download .nbib Format: NLM
Carvedilol in chronic heart failure: past, present and future.

Future cardiology

Weir RA, Dargie HJ.
PMID: 19804046
Future Cardiol. 2005 Nov;1(6):723-34. doi: 10.2217/14796678.1.6.723.

Large randomized clinical trials of bisoprolol, carvedilol and metoprolol have conclusively demonstrated the efficacy and confirmed safety of beta-blockers in patients with chronic heart failure. Recently, the beneficial effects of carvedilol in patients with heart failure soon after an...

Cite
Weir RA, Dargie HJ. Carvedilol in chronic heart failure: past, present and future. Future Cardiol. 2005;1(6):723-34doi: 10.2217/14796678.1.6.723.
Weir, R. A., & Dargie, H. J. (2005). Carvedilol in chronic heart failure: past, present and future. Future cardiology, 1(6), 723-34. https://doi.org/10.2217/14796678.1.6.723
Weir, Robin Ap, and Dargie, Henry J. "Carvedilol in chronic heart failure: past, present and future." Future cardiology vol. 1,6 (2005): 723-34. doi: https://doi.org/10.2217/14796678.1.6.723
Weir RA, Dargie HJ. Carvedilol in chronic heart failure: past, present and future. Future Cardiol. 2005 Nov;1(6):723-34. doi: 10.2217/14796678.1.6.723. PMID: 19804046.
Copy Download .nbib Format: NLM
Postural orthostatic tachycardia syndrome.

BMJ case reports

Graham U, Ritchie KM.
PMID: 21686452
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.10.2008.1132. Epub 2009 Apr 20.

Postural orthostatic tachycardia syndrome (POTS) is characterised by the development of excessive tachycardia on standing with maintained blood pressure. We report a case of POTS in a 20-year-old girl with type 1 diabetes who presented with a 3-week history...

Cite
Graham U, Ritchie KM. Postural orthostatic tachycardia syndrome. BMJ Case Rep. 2009;2009doi: 10.1136/bcr.10.2008.1132.
Graham, U., & Ritchie, K. M. (2009). Postural orthostatic tachycardia syndrome. BMJ case reports, 2009. https://doi.org/10.1136/bcr.10.2008.1132
Graham, Una, and Ritchie, Kate M. "Postural orthostatic tachycardia syndrome." BMJ case reports vol. 2009 (2009). doi: https://doi.org/10.1136/bcr.10.2008.1132
Graham U, Ritchie KM. Postural orthostatic tachycardia syndrome. BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.10.2008.1132. Epub 2009 Apr 20. PMID: 21686452; PMCID: PMC3029273.
Copy Download .nbib Format: NLM
Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release.

ISRN pharmaceutics

Malakar J, Nayak AK, Goswami S.
PMID: 23378933
ISRN Pharm. 2012;2012:730624. doi: 10.5402/2012/730624. Epub 2012 Dec 10.

The aim of this investigation was to develop and optimize bisoprolol fumarate matrix tablets for sustained release application by response surface methodology based on 2(3) factorial design. The effects of the amounts of calcium alginate, HPMC K4M, and Carbopol...

Cite
Malakar J, Nayak AK, Goswami S. Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release. ISRN Pharm. 2012;2012:730624doi: 10.5402/2012/730624.
Malakar, J., Nayak, A. K., & Goswami, S. (2012). Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release. ISRN pharmaceutics, 2012730624. https://doi.org/10.5402/2012/730624
Malakar, Jadupati, et al. "Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release." ISRN pharmaceutics vol. 2012 (2012): 730624. doi: https://doi.org/10.5402/2012/730624
Malakar J, Nayak AK, Goswami S. Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release. ISRN Pharm. 2012;2012:730624. doi: 10.5402/2012/730624. Epub 2012 Dec 10. PMID: 23378933; PMCID: PMC3529867.
Copy Download .nbib Format: NLM
Oral bisoprolol improves surgical field during functional endoscopic sinus surgery.

Journal of anaesthesiology, clinical pharmacology

Jacob SM, Chandy TT, Cherian VT.
PMID: 24574595
J Anaesthesiol Clin Pharmacol. 2014 Jan;30(1):59-64. doi: 10.4103/0970-9185.125705.

BACKGROUND: The success of functional endoscopic sinus surgery (FESS) depends on visual clarity of the surgical field, through the endoscope. The objective of this double-blind, randomized, controlled study was to determine if a pre-operative dose of bisoprolol (2.5 mg)...

Cite
Jacob SM, Chandy TT, Cherian VT. Oral bisoprolol improves surgical field during functional endoscopic sinus surgery. J Anaesthesiol Clin Pharmacol. 2014;30(1):59-64doi: 10.4103/0970-9185.125705.
Jacob, S. M., Chandy, T. T., & Cherian, V. T. (2014). Oral bisoprolol improves surgical field during functional endoscopic sinus surgery. Journal of anaesthesiology, clinical pharmacology, 30(1), 59-64. https://doi.org/10.4103/0970-9185.125705
Jacob, Sumitha Mary, et al. "Oral bisoprolol improves surgical field during functional endoscopic sinus surgery." Journal of anaesthesiology, clinical pharmacology vol. 30,1 (2014): 59-64. doi: https://doi.org/10.4103/0970-9185.125705
Jacob SM, Chandy TT, Cherian VT. Oral bisoprolol improves surgical field during functional endoscopic sinus surgery. J Anaesthesiol Clin Pharmacol. 2014 Jan;30(1):59-64. doi: 10.4103/0970-9185.125705. PMID: 24574595; PMCID: PMC3927294.
Copy Download .nbib Format: NLM
Cement-augmented dorsal instrumentation of the spine as a safe adjunct to the multimodal management of metastatic pheochromocytoma: a case report.

Patient safety in surgery

Rittirsch D, Battegay E, Zimmerli LU, Baulig W, Spahn DR, Ossendorf C, Wanner GA, Simmen HP, Werner CM.
PMID: 22222147
Patient Saf Surg. 2012 Jan 05;6(1):1. doi: 10.1186/1754-9493-6-1.

Malignant pheochromocytoma is a neuroendocrine tumor that originates from chromaffin tissue. Although osseous metastases are common, metastatic dissemination to the spine rarely occurs.Five years after primary diagnosis of extra-adrenal, abdominal pheochromocytoma and laparoscopic extirpation, a 53-year old patient presented...

Cite
Rittirsch D, Battegay E, Zimmerli LU, et al. Cement-augmented dorsal instrumentation of the spine as a safe adjunct to the multimodal management of metastatic pheochromocytoma: a case report. Patient Saf Surg. 2012;6(1):1doi: 10.1186/1754-9493-6-1.
Rittirsch, D., Battegay, E., Zimmerli, L. U., Baulig, W., Spahn, D. R., Ossendorf, C., Wanner, G. A., Simmen, H. P., & Werner, C. M. (2012). Cement-augmented dorsal instrumentation of the spine as a safe adjunct to the multimodal management of metastatic pheochromocytoma: a case report. Patient safety in surgery, 6(1), 1. https://doi.org/10.1186/1754-9493-6-1
Rittirsch, Daniel, et al. "Cement-augmented dorsal instrumentation of the spine as a safe adjunct to the multimodal management of metastatic pheochromocytoma: a case report." Patient safety in surgery vol. 6,1 (2012): 1. doi: https://doi.org/10.1186/1754-9493-6-1
Rittirsch D, Battegay E, Zimmerli LU, Baulig W, Spahn DR, Ossendorf C, Wanner GA, Simmen HP, Werner CM. Cement-augmented dorsal instrumentation of the spine as a safe adjunct to the multimodal management of metastatic pheochromocytoma: a case report. Patient Saf Surg. 2012 Jan 05;6(1):1. doi: 10.1186/1754-9493-6-1. PMID: 22222147; PMCID: PMC3293075.
Copy Download .nbib Format: NLM
Chiral Recognition Mechanisms of four β-Blockers by HPLC with Amylose Chiral Stationary Phase.

Iranian journal of pharmaceutical research : IJPR

Wang D, Li F, Jiang Z, Yu L, Guo X.
PMID: 25237340
Iran J Pharm Res. 2014;13(2):449-57.

The high performance liquid chromatography (HPLC) enantioseparation of four β-blocking agents metoprolol, bisoprolol, propranolol and atenolol was performed on amylose tris-(3,5-dimethylphenylcarbamate) chiral stationary phase using n-hexane-ethanol-diethylamine (DEA) as the mobile phase and related chiral recognition mechanisms were discussed. Enantiomeric...

Cite
Wang D, Li F, Jiang Z, et al. Chiral Recognition Mechanisms of four β-Blockers by HPLC with Amylose Chiral Stationary Phase. Iran J Pharm Res. 2014;13(2):449-57
Wang, D., Li, F., Jiang, Z., Yu, L., & Guo, X. (2014). Chiral Recognition Mechanisms of four β-Blockers by HPLC with Amylose Chiral Stationary Phase. Iranian journal of pharmaceutical research : IJPR, 13(2), 449-57.
Wang, Dongmei, et al. "Chiral Recognition Mechanisms of four β-Blockers by HPLC with Amylose Chiral Stationary Phase." Iranian journal of pharmaceutical research : IJPR vol. 13,2 (2014): 449-57.
Wang D, Li F, Jiang Z, Yu L, Guo X. Chiral Recognition Mechanisms of four β-Blockers by HPLC with Amylose Chiral Stationary Phase. Iran J Pharm Res. 2014;13(2):449-57. PMID: 25237340; PMCID: PMC4157020.
Copy Download .nbib Format: NLM
Development and evaluation of fixed dose bi therapy sublingual tablets for treatment stress hypertension and anxiety.

Journal of pharmacy & bioallied sciences

El-Nabarawi MA, Tayel SA, Soliman NA, Abo Enin HA.
PMID: 24082695
J Pharm Bioallied Sci. 2013 Jul;5(3):191-201. doi: 10.4103/0975-7406.116803.

OBJECTIVE: A stress induced rise in the blood pressure. Some believe that patients with hypertension are characterized by a generalized state of increased anxiety.AIM: The purpose of this study is to prepare a fixed dose bi therapy using bisoprolol...

Cite
El-Nabarawi MA, Tayel SA, Soliman NA, et al. Development and evaluation of fixed dose bi therapy sublingual tablets for treatment stress hypertension and anxiety. J Pharm Bioallied Sci. 2013;5(3):191-201doi: 10.4103/0975-7406.116803.
El-Nabarawi, M. A., Tayel, S. A., Soliman, N. A., & Abo Enin, H. A. (2013). Development and evaluation of fixed dose bi therapy sublingual tablets for treatment stress hypertension and anxiety. Journal of pharmacy & bioallied sciences, 5(3), 191-201. https://doi.org/10.4103/0975-7406.116803
El-Nabarawi, Mohamed A, et al. "Development and evaluation of fixed dose bi therapy sublingual tablets for treatment stress hypertension and anxiety." Journal of pharmacy & bioallied sciences vol. 5,3 (2013): 191-201. doi: https://doi.org/10.4103/0975-7406.116803
El-Nabarawi MA, Tayel SA, Soliman NA, Abo Enin HA. Development and evaluation of fixed dose bi therapy sublingual tablets for treatment stress hypertension and anxiety. J Pharm Bioallied Sci. 2013 Jul;5(3):191-201. doi: 10.4103/0975-7406.116803. PMID: 24082695; PMCID: PMC3778588.
Copy Download .nbib Format: NLM
Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate.

Blood pressure monitoring

Baguet JP, De Gaudemaris R, Mallion JM, Noirclerc M, Siché JP.
PMID: 10212353
Blood Press Monit. 1998 Jun;3(3):189-194.

BACKGROUND: Ambulatory blood pressure measurements allow better evaluation of the effects of antihypertensive drugs on the diurnal profile of blood pressure. Various strategies, such as determining peak: trough ratio and smoothness indexd, with and without smoothing of raw data...

Cite
Baguet JP, De Gaudemaris R, Mallion JM, et al. Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate. Blood Press Monit. 1998;3(3):189-194
Baguet, J. P., De Gaudemaris R, Mallion, J. M., Noirclerc, M., & Siché, J. P. (1998). Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate. Blood pressure monitoring, 3(3), 189-194.
Baguet, et al. "Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate." Blood pressure monitoring vol. 3,3 (1998): 189-194.
Baguet JP, De Gaudemaris R, Mallion JM, Noirclerc M, Siché JP. Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate. Blood Press Monit. 1998 Jun;3(3):189-194. PMID: 10212353.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 171 entries